Clinical Trial Update: A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Results posted for a completed Phase 2 trial evaluating the safety and efficacy of Sorafenib in hepatocellular carcinoma. The results were posted on 2009-08-06.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: Bayer | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED | Results posted: 2009-08-06